Lotus Pharmaceuticals, Inc.
LTUS
Rank in Stocks
#29304
Lotus Pharmaceuticals, Inc. currently has no substantial business activities.... Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Share Price
$0.0031
Last synced: 2026-11-10
Market Cap
$8.20M
Change (1 day)
0.00%
Change (1 year)
-8.82%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lotus Pharmaceuticals, Inc. (LTUS)
Category
Healthcare
EPS for Lotus Pharmaceuticals, Inc. (LTUS)
EPS as of June 2026 TTM: 0.00
According to Lotus Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Lotus Pharmaceuticals, Inc. from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | -100.00% |
| 2010 | $0.28 | -24.32% |
| 2009 | $0.37 | -38.33% |
| 2008 | $0.60 | 11.11% |
| 2007 | $0.54 | 170.00% |
| 2006 | $0.20 | 100.00% |
| 2005 | $0.10 | -33.33% |
| 2004 | $0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | - |
US
|
|
| $1.93 | - |
SE
|
|
| $6.91 | - |
FR
|
|
| $0.02 | - |
HK
|
|
| $2.71 | - |
IT
|
Questions about Lotus Pharmaceuticals, Inc.'s earnings per share (EPS)
What was Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Lotus Pharmaceuticals, Inc.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.